SHC Sotera Health

Sterigenics Announces Increased Electron Beam Sterilization Capacity to Support Healthcare Industry Needs

Sterigenics Announces Increased Electron Beam Sterilization Capacity to Support Healthcare Industry Needs

OAK BROOK, Ill., May 19, 2022 (GLOBE NEWSWIRE) -- ®, a business of Sotera Health, and a global leader in comprehensive sterilization services, announced today the beginning of processing at its expanded electron beam (“E-beam”) facility located in Columbia City, Indiana. The Sterigenics Columbia City facility provides mission-critical E-beam sterilization services to help ensure the safety of medical devices and drug products used across the global healthcare industry. The new E-beam accelerator will significantly increase the capacity of the medical and pharmaceutical products that can be sterilized at the Columbia City facility.

“The installation of a new E-beam accelerator in Columbia City is exciting and allows our team to sterilize more healthcare products that touch the lives of millions of patients across the globe,” said Jeff Blakely, General Manager, Sterigenics Columbia City. “The new E-beam has begun to process products and help us meet the growing needs of our customers, while continuing our tradition of quality performance, technical expertise and outstanding customer service,” adds Blakely. “As part of the expansion in Columbia City we have scaled our process automation to create higher levels of productivity, greater reliability, and improved safety,” said Sergio Salas, Vice President, Operations, Sterigenics.

Driven by its mission, Safeguarding Global Health®, Sterigenics and its sister businesses Nordion® and Nelson Labs® are committed to supporting the medical device and pharmaceutical industries with safe and reliable sterilization and lab testing services.

About Sterigenics: ® is a leading global provider of outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets. With our industry recognized scientific and technological expertise we help to ensure the safety of millions of patients and healthcare practitioners around the world every year. Across our 48 facilities worldwide, we offer our customers a complete range of outsourced terminal sterilization services, primarily using the three major sterilization technologies: gamma irradiation, ethylene oxide processing and electron beam irradiation. We are committed to addressing the growing need for sterilization in many parts of the world and partnering with our customers to eliminate threats to human health. Learn more about Sterigenics at . Safeguarding Global Health® - with every product we sterilize.

About Sotera Health: is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – ®, ® and ®. Sotera Health is committed to its mission, Safeguarding Global Health®.

Media Contact

Amie Casson

Director of Global Marketing



EN
19/05/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sotera Health

 PRESS RELEASE

Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Pro...

Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook 2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 20242025 Adjusted EBITDA(1) increased 8.2% to $594 million, compared to 2024, or 7.8% on a constant currency basis2025 Adjusted EPS(1) of $0.86, an increase of $0.16 per diluted share, compared to 2024Full-year 2026 outlook: net revenues growth of 5.0% to 6.5% an...

 PRESS RELEASE

Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Rel...

Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date CLEVELAND, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2025 before the market opens on Tuesday, February 24, 2026. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s ...

 PRESS RELEASE

Sotera Health Appoints Richard Kyle to the Board of Directors

Sotera Health Appoints Richard Kyle to the Board of Directors CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced today it has appointed Richard G. Kyle as a new independent director to its Board of Directors. Mr. Kyle will serve as a member of the Leadership Development and Compensation Committee and the Nominating and Corporate Governance Committee of the Board of Directors. Most recently, Mr. Kyle serve...

 PRESS RELEASE

Sotera Health to Showcase Continued Revenue Growth and Strategic Value...

Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, is presenting today at the 44th Annual J.P. Morgan Healthcare Conference. During the presentation, Management will be providing an update on Sotera Health’s business. “Sotera Health continued its solid g...

 PRESS RELEASE

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Con...

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. Company representatives will also participate in investor meetings during th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch